Document Detail


Melatonin-estrogen interactions in breast cancer.
MedLine Citation:
PMID:  15813897     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this article, we review the experimental data supporting an oncostatic role of melatonin on hormone-dependent mammary tumors. Beginning with the evidence on the role of estrogens in breast cancer etiology and mammary tumor growth, we summarize the actual therapeutic strategies with estrogens as a target. Additionally, we demonstrate that melatonin fulfills all the requirements to be considered as an antiestrogenic drug which shares properties with drugs of the two main pharmacological groups of substances which interact with the estrogen-signaling pathways such as: (i) drugs that act through the estrogen receptor interfering with the effects of endogenous estrogens; and (ii) drugs that interfere with the synthesis of estrogens by inhibiting the enzymes controlling the interconversion from their androgenic precursors. Furthermore, melatonin decreases circulating levels of estradiol. These three antiestrogenic mechanisms suggest that melatonin may have an important role in the prevention and treatment of hormone-dependent mammary cancer.
Authors:
Emilio J Sánchez-Barceló; Samuel Cos; Dolores Mediavilla; Carlos Martínez-Campa; Alicia González; Carolina Alonso-González
Related Documents :
338887 - In vitro studies on drug--antibiotic interactions i: analgesics, antipyretics, antimala...
15234747 - Pharmacokinetic and pharmacodynamic drug interactions with kava (piper methysticum fors...
10956047 - Interaction of the antitumor drug 9-aminoacridine with guanidinobenzoatase studied by s...
11090827 - Surface active drugs: self-association and interaction with membranes and surfactants. ...
2728327 - Determination of the efficacy of pyrantel pamoate at the therapeutic dose rate against ...
18003497 - The neuroprobes project.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Journal of pineal research     Volume:  38     ISSN:  0742-3098     ISO Abbreviation:  J. Pineal Res.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-04-07     Completed Date:  2005-07-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8504412     Medline TA:  J Pineal Res     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  217-22     Citation Subset:  IM    
Affiliation:
Department of Physiology and Pharmacology, School of Medicine, University of Cantabria, Santander, Spain. barcelo@unican.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / physiopathology*
Estrogens / physiology*
Female
Humans
Melatonin / physiology*
Selective Estrogen Receptor Modulators
Chemical
Reg. No./Substance:
0/Estrogens; 0/Selective Estrogen Receptor Modulators; 73-31-4/Melatonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analogues of arginine vasopressin and its agonist and antagonist modified in the N-terminal part of ...
Next Document:  Exogenous melatonin enhances bile flow and ATP levels after cold storage and reperfusion in rat live...